BioNTech SE (BNTX)
NASDAQ: BNTX · Real-Time Price · USD
120.01
+2.13 (1.81%)
At close: Feb 21, 2025, 4:00 PM
122.02
+2.01 (1.67%)
After-hours: Feb 21, 2025, 6:36 PM EST
BioNTech SE Employees
BioNTech SE had 6,133 employees as of December 31, 2023. The number of employees increased by 1,603 or 35.39% compared to the previous year.
Employees
6,133
Change (1Y)
1,603
Growth (1Y)
35.39%
Revenue / Employee
$552,861
Profits / Employee
-$84,909
Market Cap
28.77B
Employees Chart
Employees History
Date | Employees | Change | Growth |
---|---|---|---|
Dec 31, 2023 | 6,133 | 1,603 | 35.39% |
Dec 31, 2022 | 4,530 | 1,448 | 46.98% |
Dec 31, 2021 | 3,082 | 1,141 | 58.78% |
Dec 31, 2020 | 1,941 | 631 | 48.17% |
Dec 31, 2019 | 1,310 | - | - |
Sources: Annual number of employees according to filings submitted to the U.S. Securities and Exchange Commission (SEC). Data is also manually gathered from company press releases, IPO filings, and other official sources.
Related Stocks
Company Name | Employees |
---|---|
UnitedHealth Group | 440,000 |
Johnson & Johnson | 131,900 |
Thermo Fisher Scientific | 122,000 |
Abbott Laboratories | 114,000 |
AstraZeneca | 89,900 |
Novo Nordisk | 77,349 |
Novartis AG | 75,883 |
Merck & Co. | 72,000 |
BNTX News
- 17 days ago - Vaccine, packaged food stocks fall as Kennedy moves closer to health secretary job - Reuters
- 17 days ago - Vaccine stocks fall as Senate panel advances RFK Jr.'s nomination for HHS secretary - CNBC
- 18 days ago - BioNTech Completes Acquisition of Biotheus - GlobeNewsWire
- 5 weeks ago - BioNTech Provides Business and Pipeline Updates at 43rd Annual J.P. Morgan Healthcare Conference - GlobeNewsWire
- 5 weeks ago - Top 5 Cancer Pharma Stocks With Strong Risk/Reward In 2025 - Seeking Alpha
- 6 weeks ago - BioNTech Positioned For Solid Growth Amid Oncology Transition: Analyst - Benzinga
- 2 months ago - BioNTech enters settlement with US agency, UPenn over COVID vaccine royalties - Reuters
- 2 months ago - US FDA lifts partial clinical hold on BioNTech cancer drug study - Reuters